In the big picture, matched sibling donor transplants remain the standard of care, Boelens said. But gene therapy is ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

Private jets owned by six of the largest U.S. drugmakers have touched down in Washington-area airports 127 times this year, ...

One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Merck Foundation Chairman & Chief Executive Officer (CEO) and the First Lady of Zimbabwe Celebrate 7 Years of Long-Term ...

Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.